ExploreWatchlistsPricing
  1. JP-listed companies
  2. Japan Tissue Engineering Co., Ltd.
  3. Financials
  4. Total current liabilities

Japan Tissue Engineering Co., Ltd. (7774)

Market cap
¥24.7B
P/E ratio
-45.6x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current liabilities (Million JPY)YoY (%)
Mar 31, 2025637-27.05%
Mar 31, 2024874-4.14%
Mar 31, 2023911+1.63%
Mar 31, 2022897-2.44%
Mar 31, 2021919+17.23%
Mar 31, 2020784-1.50%
Mar 31, 2019796+8.46%
Mar 31, 2018734+47.23%
Mar 31, 2017498+1.69%
Mar 31, 2016490+41.60%
Mar 31, 2015346

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat